Sana Biotechnology, Inc.’s SANA share price has surged by 7.80%, which has investors questioning if this is right time to sell.

Vir Biotechnology, Inc.’s VIR share price has surged by 5.82%, which has investors questioning if this is right time to sell.

The resurrection of the dire wolf by Colossal Biosciences marks a fascinating intersection of popular culture and ...

Two years ago, the Pharmaceutical Research and Manufacturers of America (PhRMA) trade group faced a mini-exodus as several ...

Scientific discovery knows no geographical, communal, religious, ethnic, or political bias. It belongs universally and ...

The relationship between pathology in the brain and alterations in the gut microbiome could lead to therapies — even if it’s ...

The same drive that fueled the events of 1775 has made our state a cradle for breakthroughs in industry, technology, and ...

Images of a baby colossal squid this week reminds us that the deep sea is an almost inexhaustible source of awe.

MICHAEL BECKLEY is Associate Professor of Political Science at Tufts University, a Nonresident Senior Fellow at the American ...

Sweeping funding cuts threaten to undermine the innovation that has been a central part of US economic strength for decades ...